Sanofi and GSK to seek regulatory authorization for COVID- 19 vaccine, Health News, ET HealthWorld
February 23, 2022. Sanofi and GSK today announce that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory applications for…

